A comprehensive view of Olympus America Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
Olympus to present its diverse treatment portfolio at the American Urological Assn. annual meeting; Olympus to showcase its FDA-cleared RenaFlex single-use ureteroscope system and ESG-410 surgical energy platform
Published:
April 30, 2024
by Olympus America Inc.
|
Olympus reports positive policy changes by commercial payers is extending coverage for iTind, its minimally invasive treatment for benign prostatic hyperplasia; policy updates may affect up to 27 million enrollees in the US
Published:
April 15, 2024
by Olympus America Inc.
|
Olympus announces full market availability of new ESG-410 Surgical Energy Platform, which will be on display at the annual meeting of the Society of Thoracic Surgeons in San Antonio, Texas, Jan. 27-29
Published:
January 24, 2024
by Olympus America Inc.
|
Olympus Corporation completes acquisition of Taewoong Medical, a South Korea-based manufacturer of gastrointestinal medical devices; US$370M deal strengthens Olympus's Therapeutic Solutions Division, expands its GI EndoTherapy product offerings
Published:
January 24, 2024
by Olympus America Inc.
|
Olympus launches its next-generation EVIS X1 endoscopy system and will demonstrate it at American College of Gastroenterology annual meeting; system designed to enhance the visualization capability of lesions, polyps, deep blood vessels, bleeding points
Published:
October 19, 2023
by Olympus America Inc.
|
Ask us about our Transformation & Innovation market view